Objective: To study the clinical value of cerebral glucose metabolism measure by 18 F-fluorodeoxyglucose 18 F-FDG PET in preterm, term newborn infants and neonatal hypoxic-ischemic encephalopathy (HIE).
F-fluorodeoxyglucose 18 F-FDG PET in preterm, term newborn infants and neonatal hypoxic-ischemic encephalopathy (HIE).
Methods:
To measure the cerebral glucose metabolism by 18 F-FDG PET imaging in newborn infants. Sixty infants were included in the study. The data was collected by PET instrument after administration of 0.1mCi /kg 18 F-FDG, and standardized uptake values (SUV) were calculated to estimate the cerebral glucose metabolism.
Results:
The cerebral glucose metabolism was found to have a trend to be increased, and the structure of brain 18 F-FDG PET imaging to be clear with the increase of gestational age, especially when the gestational age was older than 37wk. The brain 18 F-FDG PET imaging in different gestational age showed that the uptake of 18 F-FDG was relatively higher in thalamus, cerebellum, sensorimotor cortex and basal ganglia, where as relatively lower in cerebral cortex. The uptakes of 18 F-FDG in ≥37wk group were found to be significantly higher than those in ≤32wk group (p< 0.01). The cerebral glucose metabolism was significantly changed in neonatal HIE. The cerebral uptake of 18 F-FDG was either unbalanced bilaterally or relatively low in all sites especially in subcortical alba, thalamus, basal ganglia in HIE patients. Moreover, The uptakes of 18 F-FDG in severe HIE patients were found to be significantly lower than those in mild and medium HIE patients(p< 0.05).
Conclusions:
Cerebral glucose metabolism measured by 18 F-FDG PET might be a useful tool for estimating the brain development and injury in newborn infants, and its clinical values need further investigating.
